Anteris Technologies Global Corp. (ASX:AVR)
Australia flag Australia · Delayed Price · Currency is AUD
7.50
+1.88 (33.45%)
Apr 24, 2025, 3:59 PM AEST

Anteris Technologies Global Company Description

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases.

It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve.

The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta.

Anteris Technologies Global Corp. is based in Toowong, Australia.

Anteris Technologies Global Corp.
Anteris Technologies Global logo
Country United States
Founded 1999
Industry Medical Devices
Sector Healthcare
Employees 136
CEO Wayne Paterson

Contact Details

Address:
Toowong Tower
Toowong, Delaware 4066
Australia
Phone 61 7 3152 3200
Website anteristech.com

Stock Details

Ticker Symbol AVR
Exchange Australian Securities Exchange
Fiscal Year January - December
Reporting Currency USD
ISIN Number AU0000088841
SIC Code 3842

Key Executives

Name Position
Wayne Geoffrey Paterson Vice Chairman and Chief Executive Officer
David St. Denis President and Director
Matthew McDonnell Chief Financial Officer
Stephen Anthony Denaro Non-Executive Director and Company Secretary
Dr. Chris Meduri M.D., M.P.H. Chief Medical Officer and Member of Medical Advisory Board